Executive Summary
Global Rank
#~1.73M
Monthly Visits
10,412
Avg Duration
3m 5s
Pages/Visit
3.92
Strategic Overview
A highly recognizable name in a niche that generates public attention., Long-lived domain history dating back to 1997., A small but persistent direct brand search demand..
Extremely poor credibility in mainstream reporting., No independently verified evidence supporting its core product claims., High legal, ethical, and reputational exposure., Sparse contactability and weak operational transparency., Traffic is small for a site making such large claims..
Our Verdict
Upside & Downside Analysis
The Bull Case
3 PointsBrand persistence
- The domain has operated for decades and still attracts branded searches.
- The name is distinctive and easy to remember.
- It continues to receive some direct and organic traffic despite the controversy.
Niche attention
- The topic has always drawn media interest, so the site has unusual awareness for its size.
- A controversial brand can stay visible for a long time if it remains part of public debate.
Simple technical footprint
- The site runs on conventional infrastructure with HTTPS and standard hosting.
- That makes the site easy to maintain, even if the business case is weak.
The Bear Case
4 PointsCore claims are not credible
- Independent reporting has long treated the cloning claims as unproven.
- No verifiable evidence of human cloning is present in the evidence set.
- That makes the central offer commercially and scientifically weak.
Severe trust and ethics problem
- The brand is linked to the Raëlian movement and has been described as a sham in media coverage.
- That association is a major barrier to trust, partnerships, and payment relationships.
High legal exposure
- Human cloning claims sit in a heavily restricted ethical and legal zone.
- Public investigations and warnings increase the chance of enforcement or platform restrictions.
Low-quality operating profile
- Traffic is modest, with about 10.4k estimated visits in the latest month shown.
- Contact data is sparse and there is no LinkedIn company presence in the data.
Domain Integrity
The domain is old and technically active, with GoDaddy registration, InMotion DNS/hosting, and valid HTTPS. The age is a positive technical signal, but it does not reduce the major credibility and regulatory concerns tied to the business model.
| Registrar | GoDaddy.com, LLC |
|---|---|
| Domain Age | Jan 10, 1997 (29 years old) |
| Security Status |
Registry Locked
SSL: R12
|
Reputation
0 Reviews
Sentiment Analysis
There is no populated Trustpilot-style review profile in the evidence. Instead, the reputation footprint comes from longstanding negative media coverage, scientific skepticism, and legal disputes over unverified cloning claims.
Common Themes
Traffic Distribution
| Top Countries | Traffic Share | Trend |
|---|---|---|
|
United States
|
59.14% |
|
|
Canada
|
40.86% |
|
Competition
| Competitor Type | Threat Analysis |
|---|---|
| Mainstream fertility and reproductive medicine providers | They offer legitimate services, licensed clinicians, and regulatory compliance, which makes Clonaid’s claims look far less credible. |
| Academic and clinical genetics research groups | They set the scientific standard for evidence, peer review, and ethics, all of which Clonaid lacks. |
| Bioethics and public health institutions | They shape public policy and opinion against human cloning claims and raise the bar for acceptable conduct. |
SWOT Analysis
Strengths
- Long domain age and persistent brand recognition.
- Small but measurable traffic and brand-search demand.
- Simple, maintainable technical infrastructure.
Weaknesses
- No verified proof for the core service claim.
- Very weak trust and reputation profile.
- Sparse public contact information and no LinkedIn company presence.
Opportunities
- Could be analyzed as a historical case study in media, ethics, and scam dynamics.
- Could attract niche archival or investigative interest.
- The brand still has awareness value despite its baggage.
Threats
- Ongoing regulatory scrutiny of cloning-related claims.
- Public and media skepticism that is unlikely to fade.
- High risk of being treated as deceptive or unethical by partners and platforms.
Tech Stack
Hosting and DNS
The site uses InMotion Hosting DNS and hosting, with older historical use of SoftLayer and HostGator. The current footprint looks like a conventional small-site setup.
Web server and stack
BuiltWith shows Apache, PHP historically, e107 CMS, jQuery, jQuery UI, and jsDelivr. This is a basic legacy web stack rather than a modern product platform.
Security
The domain uses HTTPS by default and currently has a valid SSL certificate from R12 with RSA-SHA256. The security posture is functional, but not notably advanced.
Email and delivery
DNS includes SPF and MailChannels, which suggests outbound mail handling exists. That is standard infrastructure, not a sign of operational maturity.
Key Risks
| Identified Risk | Impact | Mitigation |
|---|---|---|
| Core business claims are scientifically unverified and widely disputed. | High | Treat the site as non-credible unless independent, peer-reviewed proof is produced. Do not rely on marketing statements alone. |
| Regulatory and legal exposure around human cloning claims. | High | Assume any active commercialization in this area faces major legal review and potential enforcement. |
| Severe reputational contamination from cult and scam allegations. | High | Avoid brand association unless the objective is academic, journalistic, or legal research. |
| Sparse transparency and weak contactability. | Medium | Require verified corporate registration, direct contacts, and a real operating address before any engagement. |
| Limited economic viability due to narrow audience and tiny traffic base. | Medium | Check for durable revenue sources, licensing, or institutional backing rather than relying on site visits. |
Contacts
Appendix & Sources
Key Citations
-
SimilarWeb traffic and engagement data for clonaid.com
Used for estimated monthly visits, traffic mix, engagement, and country share.
-
WHOIS, DNS, and SSL data for clonaid.com
Used for registrar, creation date, nameservers, and certificate details.
-
BuiltWith technology profile for clonaid.com
Used for hosting, server, CMS, JavaScript, email, and SSL infrastructure signals.
-
Website contacts scraper output for clonaid.com
Used to confirm the absence of visible email and phone contacts and note scraped social links.
-
Google Safe Browsing status for clonaid.com
Used to verify that no active malware or phishing warning was returned.
-
Google News and public reporting on Clonaid
Used to support the long-running credibility and dispute history around the brand.
-
Perplexity research summary on complaints and disputes
Used to synthesize scam reports, lawsuit context, and reputation concerns.
-
USPTO trademark search for Clonaid
Used to confirm no trademark records were returned for the query.
-
LinkedIn business search result
Used to confirm the domain was not found on LinkedIn as a company profile.
-
Google Places lookup for clonaid.com
Used to confirm there was no physical business listing surfaced in the lookup.
Data Sources Used
Disclaimer
This report is based on the supplied evidence bundle and public signals only. It is not legal advice, and it should not be treated as proof of wrongdoing or as a substitute for direct corporate verification.